Biocides

Microban(r) Backs Antimicrobial Additives as a Scientifically Supported Strategy for Cleaner Building Materials

Thursday, May 13, 2021 - 2:41pm

This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning.

Key Points: 
  • This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning.
  • Making a clear distinction between public health and non-public health claims, Microban has explained the advantages of incorporating its antimicrobial additives into building materials to protect articles from degradation by mold, mildew, and odor-causing microbes.
  • As demand for antimicrobial additives increases, this has never been more important.
  • Our proactive systems keep products cleaner, and control odors better by preventing problems before they start.

ILC Therapeutics Announces Board Changes and Funding Round to Accelerate Covid-19 Drug

Thursday, May 13, 2021 - 9:10am

In some cases (SARS, MERS, Covid-19), viruses can evade the interferon response by delaying the innate immune response.

Key Points: 
  • In some cases (SARS, MERS, Covid-19), viruses can evade the interferon response by delaying the innate immune response.
  • A therapeutic like Alfacyte\xe2\x84\xa2 can offer enhanced interference to Covid-19 replication in the body and activate the body\xe2\x80\x99s own Natural Killer (NK) cells to fight virus infection.
  • Alfacyte\xe2\x84\xa2 has the potential to become an important antiviral treatment in the ongoing fight against RVI\xe2\x80\x99s in general and Covid-19 in particular.
  • It is also a vital treatment for those who are not able to take vaccines or choose not to.

An oral antiviral drug from Korea may be a problem solver for COVID-19

Thursday, May 13, 2021 - 9:37am

(See graph 1)\nThe decreased viral load in the treated group results from Niclosamide\'s antiviral mechanism in both suppressing viral replication and deactivating the virus (virucidal).

Key Points: 
  • (See graph 1)\nThe decreased viral load in the treated group results from Niclosamide\'s antiviral mechanism in both suppressing viral replication and deactivating the virus (virucidal).
  • This study may be the world\'s first in vivo evidence for anthelminthic Niclosamide to be repurposed as an antiviral drug in oral formulation.\nCNPharm\'s CP-COV03 is now expected to compete with other COVID-19 antiviral oral drug candidates, such as Pfizer\'s PF-07321332 and Merck\'s MK-4482.
  • Since Tamiflu was developed for H1N1, it has been recognized that cutting edge biotechnology is required to develop such antiviral drugs successfully.
  • CNPharm developed CP-COV03 to repurpose Niclosamide with its drug delivery system technology, and successfully improved bioavailability and the half-life of Niclosamide.

Vyv Announces Groundbreaking Inactivation And Killing Of Viruses With Its UV-free Antimicrobial Light Technology

Wednesday, May 12, 2021 - 1:00pm

b'LATHAM, N.Y., May 12, 2021 /PRNewswire/ --Vyv, a female founded and led health-tech industry leader and pioneer of antimicrobial LED technology, announces the recent independent test results confirming efficacy of its antimicrobial light technology (405nm) for killing* viruses.

Key Points: 
  • b'LATHAM, N.Y., May 12, 2021 /PRNewswire/ --Vyv, a female founded and led health-tech industry leader and pioneer of antimicrobial LED technology, announces the recent independent test results confirming efficacy of its antimicrobial light technology (405nm) for killing* viruses.
  • The recent findings of enhanced efficacy against viruses greatly expands the antimicrobial impact delivered to spaces currently protected with Vyv technology, as well as in new spaces," said Vyv CEO and co-founder Colleen Costello.
  • Unlike UV-C light, Vyv meets international standards for continual and unlimited use around people in homes, public places and across industries.
  • Use of Vyv antimicrobial light is not intended to replace manual cleaning.\n'

Qpex Biopharma Initiates Phase 1 Study of ORAvance™ for Oral Treatment of Drug-Resistant Gram-Negative Bacterial Infections

Wednesday, May 12, 2021 - 1:00pm

The World Health Organization (WHO) has also prioritized development of new treatments for these pathogens.

Key Points: 
  • The World Health Organization (WHO) has also prioritized development of new treatments for these pathogens.
  • Two of the products use QPX7728, an ultra-broad-spectrum beta-lactamase inhibitor that restores the potency of beta-lactam antibiotics in vitro and in vivo.
  • Qpex\xe2\x80\x99s current collaboration with BARDA is focused on advancing a portfolio of novel antibiotics, including the QPX7728-based products OMNIvance and ORAvance.
  • For more information, please visit www.qpexbio.com and follow us on Twitter and LinkedIn .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210512005284/en/\n'

Vive Crop Protection receives EPA approval for the world's first three-way biological, chemical and Allosperse fungicide

Tuesday, May 11, 2021 - 12:00pm

b'TORONTO, May 11, 2021 /PRNewswire/ - AZterknotTM fungicide from Vive Crop Protection received approval from the U.S. Environmental Protection Agency recently.\nAZterknot fungicide is the world\'s first three-way fungicide combination that harnesses the benefits of biologicals, the performance of chemistry and the ease of Allosperse.

Key Points: 
  • b'TORONTO, May 11, 2021 /PRNewswire/ - AZterknotTM fungicide from Vive Crop Protection received approval from the U.S. Environmental Protection Agency recently.\nAZterknot fungicide is the world\'s first three-way fungicide combination that harnesses the benefits of biologicals, the performance of chemistry and the ease of Allosperse.
  • For the first time, we have used Vive\'s patented Allosperse Delivery System to combine a biological and a chemical in the same jug.
  • "\nAnderson continues, "AZterknot is the first step in mobilizing the power of both biological and chemical active ingredients, using our Allosperse technology.
  • Using the Allosperse Delivery System, Vive greatly improves the targeting and performance of chemical and biological active ingredients, helping growers achieve real results.\nAZterknot and Allosperse are trademarks of Vive Crop Protection.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/vive-crop-protection-receives-ep...\n'

Bee Vectoring Technologies: Invitation to the Q2 Virtual Investor Summit

Tuesday, May 11, 2021 - 12:00pm

b'BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market.

Key Points: 
  • b'BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the $240 billion crop protection and fertilizer market.
  • BVT has pioneered a natural precision agriculture system that replaces chemical pesticides and wasteful plant protection product spray applications by delivering biological pesticide alternatives to crops using commercially grown bees.
  • Currently, BVT has over 65 granted patents, over 35 patents pending in all major agricultural countries worldwide, and has US EPA registration of its Vectorite\xe2\x84\xa2 with CR-7 (EPA Registration No.
  • 90641-2) for sale as a registered biological fungicide for use on the labeled crops.Additional information can be viewed at the Company\xe2\x80\x99s website www.beevt.com .\n'

Insights on the Agricultural Biologicals Global Market to 2026 - Growing Demand for Food Owing to Booming Population Growth is Driving the Industry - ResearchAndMarkets.com

Monday, May 10, 2021 - 9:59am

Agricultural biologicals are a distinctive group of natural products, derived from naturally occurring micro-organisms, beneficial insects, plant extracts, and other organic matters.\nBiological products, such as agricultural biologicals, are the fastest-growing segments in the agricultural input market.

Key Points: 
  • Agricultural biologicals are a distinctive group of natural products, derived from naturally occurring micro-organisms, beneficial insects, plant extracts, and other organic matters.\nBiological products, such as agricultural biologicals, are the fastest-growing segments in the agricultural input market.
  • the key developer of this industry is the growing demand for eco-friendly, chemical-free products for better yield.
  • Chemical fertilizers and pesticides do increase yield, at the cost of the quality of the crop.
  • Agricultural Biologicals, on the other hand, do not contain chemicals and make the plant and yield more nutritious and healthier.

BIOSt® Nematicide Seed Treatment Reduces Greenhouse Gas Emissions in Soybeans and Corn by 85%+ Compared to Conventional Pesticides

Thursday, May 6, 2021 - 1:31pm

(NASDAQ: MBII) (MBI), an international leader in sustainable agricultural biological solutions, announced today that BIOSt Nematicide seed treatment product, achieved an outstanding climate impact score of 9.8 out of 10.\nThe Climate Impact Study showed that BIOSt Nematicide reduced greenhouse gas (GHG) emissions by 85 percent in soybeans and 87 percent in corn compared with conventional pesticides.

Key Points: 
  • (NASDAQ: MBII) (MBI), an international leader in sustainable agricultural biological solutions, announced today that BIOSt Nematicide seed treatment product, achieved an outstanding climate impact score of 9.8 out of 10.\nThe Climate Impact Study showed that BIOSt Nematicide reduced greenhouse gas (GHG) emissions by 85 percent in soybeans and 87 percent in corn compared with conventional pesticides.
  • It is approved for conventional and organic use and is safe for human use, pollinators (such as bees), and aquatic life.
  • This new data underscores the beneficial experience our distribution partners and grower customers have had with BIOSt Nematicide in row crops such as soybeans, corn, and cotton.
  • This study concluded that the use of MBI\xe2\x80\x99s bioprotectants would likely reduce GHG emissions by 69 to 91 percent when compared with conventional pesticides.

HeiQ launches high-tech mask featuring ground-breaking copper technology shown to deactivate the COVID-19 virus in five minutes

Wednesday, May 5, 2021 - 9:00am

HeiQ MetalliX is a patent-pending technology, created by HeiQ\'s innovation partner,Australian materials technology company, Xefco.

Key Points: 
  • HeiQ MetalliX is a patent-pending technology, created by HeiQ\'s innovation partner,Australian materials technology company, Xefco.
  • The antiviral, antibacterial and antifungal properties of copper have been known for centuries and have been demonstrated by many laboratory studies.
  • HeiQ MetalliX treated materials release copper ions which deactivate viruses and bacteria.
  • Further, it gives an edgy look, making it an improved alternative to surgical masks in many ways," says Carlo Centonze, co-founder and CEO of HeiQ Group.\n'